LAGIPRA peptide TFA
Based on 1 Customer Validation
LAGIPRA peptide TFA is a long-acting GIP1R agonist. LAGIPRA peptide TFA enhances insulin sensitivity by augmenting glucose disposal and reduces branched-chain amino acids (BCAAs) and ketoacids. LAGIPRA peptide TFA has the potential for the research of type 2 diabetes.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté : 99.86%
- Formule: C264H406N64O78S.xC2HF3O2
- Masse moléculaire:5756.50 (free base)
-
Stockage:
Sealed storage, away from moisture.
Powder -80°C, 2 years , -20°C, 1 year* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
-
Solvant et solubilité
- Protocole
- Pureté et documentation
- Références
-
Help & FAQs
Activité biologique
Description
In Vivo
LAGIPRA peptide (300 nmol/kg; sc; once a day for 14 days) TFA shows a small (4% reduction) effect on body weight and transient reduction (during the first 24-48 hours) in food intake, decreases fasting glucose and insulin[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Male IR mice (onsisting of 60% fat, 20% carbohydrate, and 20% protein caloric content D12492; Research Diets)[1]
-
Dosage:300 nmol/kg
-
Administration:s.c.; once a day for 14 days
-
Result:Showed a small (4% reduction) effect on body weight and transient reduction (during the first 24-48 hours) in food intake, decreases fasting glucose and insulin.
Chemical Information
-
Appearance Solid
-
Masse moléculaire 5756.50 (free base)
-
Formule C264H406N64O78S.xC2HF3O2
-
Color White to off-white
-
Synonyms
Long acting GIPRA-1 TFA
-
Sequence
Tyr-{Aib}-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-{Lys(AEEA-AEEA-γGlu-C20 diacid)}-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Asn-Asp-Trp-Lys-His-Asn-Ile-Thr-Gln
-
Sequence Shortening
Y-{Aib}-EGTFISDYSIAMDK-{Lys(AEEA-AEEA-γGlu-C20 diacid)}-HQQDFVNWLLAQKGKKNDWKHNITQ
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Sealed storage, away from moisture
Powder -80°C 2 years -20°C 1 year * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Solvant et solubilité
In Vitro:
H2O : ≥ 100 mg/mL
DMSO : 100 mg/mL (Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
* "≥" means soluble, but saturation unknown.
Pureté et documentation
-
Fiche technique (291 KB)
-
SDS (254 KB)
- English - EN (254 KB)
- Français - FR (254 KB)
- Deutsch - DE (254 KB)
- Norwegian - NO (254 KB)
- Español - ES (254 KB)
- Swedish - SV (254 KB)
- Italian - IT (254 KB)
- Korean - KR (254 KB)
- Portuguese - PT (254 KB)
-
Instruction de manipulation (2659 KB)
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
LAGIPRA peptide TFA Related Classifications
HY-P11285A Related Classifications
Powered by Bioz